Answers are grounded in this paper and cite their sources.
Background. Autonomous AI can generate candidate designs and clinical hypotheses faster than physical measurements, evidentiary review and regulatory decisions can verify them. A common failure is to treat an absent observation as zero, an inferred state as measured, or an impressive model score as operational authorization. This study formulates a single research architecture for AI systems and clinical medicine without equating their domain-specific safety requirements. Methods. We define a typed physical-and-evidentiary state ledger, an internal three-valued proof logic with binary release, a history-dependent consequence state, and falsification criteria specified before independent deployment. We derive a fail-closed admissibility result and a capacity upper bound. Retrospective public-data analyses examine 463 labeled robot execution episodes from five UCI tasks and 400 ClinicalTrials.gov-derived trial-history anchors (6,029 recorded versions). In robotics, a fixed three-nearest-neighbor diagnostic benchmark compares final-sample measurements with 15-sample temporal summaries under task-stratified fivefold cross-validation. Results. Temporal summary features yield pooled balanced accuracy 0.9563 versus 0.7551 for final-sample features, yet miss 24 of 334 labeled failures (7.19%; Wilson 95% interval 4.88%–10.47%). A proposed independent-deployment rule requiring a one-sided 95% upper miss-rate bound below 1% is therefore not met. In clinical registry records, only 338 of 400 historical pre-results primary-completion entries are both marked ACTUAL and day-precise; 62 require quarantine for an exact-date historical audit. Median time from recorded primary completion to first results submission is 388 days in this selected corpus, not a treatment-effect or compliance estimate. Conclusions. The framework supplies an implementable separation between AI proposal, deterministic evidence verification and authorized release. The executed analyses demonstrate consequential temporal information and registry-evidence incompleteness; neither constitutes clinical efficacy, medical-device clearance, or live autonomous-system safety validation. Keywords: autonomous R&D; clinical trial provenance; evidence gating; robotics; formal verification; temporal memory; falsifiability. Proprietary components The analyses were produced by software held privately by the author. The code is not distributed with this record; its existence and exact content on the publication date are fixed by the SHA-256 fingerprints below. A fingerprint identifies a file but cannot be reversed into it. Source-pinned replication engine for the robotic-diagnostic and clinical-registry analyses (content-addressed inputs) Typed-state fail-closed verifier: physical-kind units, three-valued proofs, binary release, participant reconciliation Verifier test suite SHA-256 fingerprints: replicate_study.pyc01d33f165c0d4a1002179f8afb0a12a80149021967185f653e663c772bb01bd fail_closed_verifier.pya7131f8824f7a3dc89256047bdab98b6f7ebb1d6398011e11efbe6561c0ad650 test_verifier.py6c3e620668590d7d229abb73df7909199b4e074caefbec51fefd5cbdbfa03666 Proprietary notice. The code is proprietary to Jarid Shaub. Licensed parties receive it with these fingerprints for independent verification. Commercial use, implementation, evaluation and licensing inquiries: shaub.redteam@proton.me
No takes yet. Share an insight, caveat, or question.
Jarid Shaub Shaub (2026) studied this question.
Synapse has enriched 8 closely related papers on similar clinical questions. Consider them for comparative context: